Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

In 2016, Amgen Hong Kong was established, providing access to our innovative therapeutic solutions for patients in Hong Kong and Macau suffering from illnesses. Not only did Amgen's entry in this market bring innovative therapies to individuals suffering from serious illness, it also enhances the exchange of scientific ideas and fosters more research collaborations.

Currently, Amgen Hong Kong offers full commercial capability, covering treatments for the following therapeutic areas: bone health, cardiovascular disease, oncology, hematology, and inflammatory diseases.

  • The Rhythm of Life

  • View Video Transcript

The Rhythm of Life

Find out why Amgen operates at a different rhythm, accelerating the pace of change at the cutting edge of medical discovery, inventing powerful new therapies and reliably delivering them to patients.

The rhythm of life unfolds at an ever-changing pace. Some moments pass in a blur. Others tick by in slow motion.

But no matter what the pace of life, nothing is more valuable than the time we have to experience it— and the chance we have to live each moment to its fullest.

That’s why Amgen operates at a different rhythm, moving quickly toward the future by combatting the world’s toughest diseases.

With roots in the biotech revolution, today Amgen is one of the world’s leading independent biotech companies.

With each decade, we stay on the cutting edge of medical discovery, inventing powerful therapies— and reliably delivering them to patients.

We fight the toughest diseases, such as cancer, heart disease, asthma, and osteoporosis to help millions of people globally.

We live in a new era of human health. And Amgen continues to accelerate the pace of change-- operating sustainably and drawing upon our deep knowledge of science to push beyond what’s known today.

We tap into a vast library of human and genetic data to unearth new insights into treating disease. We are creating new therapies that are more precise and personalized than ever before, advancing medicines that can work in new ways, such as targeting multiple pathways in the body at the same time.

Machine learning and artificial intelligence help us make medicines more quickly and effectively by helping to predict if they’ll be safe and effective.

We’re also removing barriers that limit equitable access to healthcare to make our medicines available to more patients around the world.

At Amgen, our mission is to serve patients because we want these rhythms of life to continue. We want you, and your loved ones, to make every moment count—and to count on having more moments.


Innovative Medicines

We have a presence in approximately 100 countries and regions worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses such as cancer, cardiovascular disease, osteoporosis, asthma, rheumatoid arthritis and many others. Our medicines typically address diseases for which there are limited treatment options, or they are medicines that provide a viable option to what is otherwise available.

We pioneer excellence in innovation

As a global leader in biologics manufacturing, Amgen has an outstanding track record of reliably delivering innovative and high-quality medicines to Asian patients. This record of success is supported by state-of-the-art facilities and global manufacturing network, along with regional capabilities to ensure quality and supply.

Amgen Hong Kong is a key clinical development hub for Amgen in the JAPAC region, facilitating collaboration between Amgen and local researchers, and leveraging their expertise to advance Amgen’s clinical pipeline. We use cutting-edge science and biotechnology to study the subtlest biological mechanisms in search of therapies that will improve the lives of patients.